Mycotopia Therapies, Inc.
OTC: TPIA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Benjamin Kaplan
- Employees
- 1
- Headquarters
- Aventura, United States
- IPO year
- 2006
- Market cap
- $113.8K
- Website
- https://www.mycotopiatherapies.com
Loading TPIA…
Loading profile data…Frequently asked questions about TPIA
What does Mycotopia Therapies, Inc. (TPIA) do?
Mycotopia Therapies, Inc. specializes in the application of psychedelic compounds to address a range of mental health conditions. The company offers therapeutic interventions for ailments such as post-traumatic stress disorder (PTSD), severe anxiety, depression, and serotonin syndrome, in addition to providing support for palliative care. Headqu...
Where does TPIA trade?
Mycotopia Therapies, Inc. (TPIA) trades on the Other OTC.
What sector is TPIA in?
Mycotopia Therapies, Inc. (TPIA) operates in the Healthcare sector, specifically in the Medical - Care Facilities industry.
Who is the CEO of Mycotopia Therapies, Inc.?
Benjamin Kaplan is the chief executive officer of Mycotopia Therapies, Inc. (TPIA).
Where is Mycotopia Therapies, Inc. headquartered?
Mycotopia Therapies, Inc. is headquartered in United States.
Does TPIA pay a dividend?
Mycotopia Therapies, Inc. (TPIA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did TPIA go public?
Mycotopia Therapies, Inc. (TPIA) completed its initial public offering in 2006.